Cargando…
Clinical Efficacy of Huangkui Capsule Plus Methylprednisolone for Immunoglobulin A Nephropathy and Its Effect on Renal Function and Serum Inflammatory Factors
OBJECTIVE: To assess the clinical efficacy of Huangkui capsule plus methylprednisolone for immunoglobulin A (IgA) nephropathy and its effect on renal function and serum inflammatory factors. METHODS: A total of 80 patients with IgA nephropathy admitted to our hospital from April 2019 to December 202...
Autores principales: | Yuan, Lili, Cai, Kan, Zou, Yueji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974270/ https://www.ncbi.nlm.nih.gov/pubmed/36865740 http://dx.doi.org/10.1155/2023/3020033 |
Ejemplares similares
-
Clinical Efficacy of Huangkui Capsule plus Methylprednisolone in the Treatment of Nephropathy and the Effect on Urinary Protein and Serum Inflammatory Factors in Patients
por: Wan, Weibo, et al.
Publicado: (2022) -
Retracted: Clinical Efficacy of Huangkui Capsule plus Methylprednisolone in the Treatment of Nephropathy and the Effect on Urinary Protein and Serum Inflammatory Factors in Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis
por: An, Wenrong, et al.
Publicado: (2021) -
Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway
por: Pei, Shuwen, et al.
Publicado: (2021) -
Network pharmacology and molecular docking predictions of the active compounds and mechanism of action of Huangkui capsule for the treatment of idiopathic membranous nephropathy
por: Cai, Meng, et al.
Publicado: (2023)